Impact of Palliative Catheter Placement on the Quality of Life of Patients With Refractory Ascites

Sponsor
Memorial Sloan Kettering Cancer Center (Other)
Overall Status
Completed
CT.gov ID
NCT01188746
Collaborator
(none)
50
1
1
114
0.4

Study Details

Study Description

Brief Summary

The purpose of this study is look at how treatments for ascites affect quality of life. Your quality of life is the ability for you to enjoy the normal things you do. Ascites (pronounced as-ī-tees) is the presence of extra fluid in the abdomen. Sometimes ascites is caused by cancer, also called malignancy.

All people who participate in this study have ascites associated with cancer. Ascites can cause symptoms that make it difficult for the patient to do simple things. Patients with ascites often report:

Abdominal swelling Difficulty walking. Difficulty breathing. Feeling full when eating. Clothes not fitting due to a swollen abdomen. Swelling in the legs. It is hoped that this catheter will relieve the symptoms of the ascites. The goal of the investigators study is to understand the quality of life before the procedure and after the procedure. Since the patient is having this procedure to make their symptoms better, the investigators want to hear from the patient of how the procedure has affected their quality of life.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: McGill Quality of Life Questionnaire and the European Organization for Research and Treatment of Cancer Quality of Life Core Questionnaire
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
50 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Impact of Palliative Catheter Placement on the Quality of Life of Patients With Refractory Ascites
Study Start Date :
Aug 1, 2010
Actual Primary Completion Date :
Feb 1, 2020
Actual Study Completion Date :
Feb 1, 2020

Arms and Interventions

Arm Intervention/Treatment
Experimental: Questionnaire or interview

A pre-experimental design was chosen to examine changes in QoL following a palliative intervention.

Behavioral: McGill Quality of Life Questionnaire and the European Organization for Research and Treatment of Cancer Quality of Life Core Questionnaire
Participants will be interviewed twice (if they chose to participate in the qualitative portion) and complete instruments at three time points: 1) immediately prior to the procedure, 2)within seven days after the procedure, preferably prior to discharge, and 3) three weeks after their catheter placement.

Outcome Measures

Primary Outcome Measures

  1. Determine if there is change in the QoL [2 years]

    of patients who have refractory ascites after the placement of a palliative catheter in Interventional Radiology.

  2. Determine if there is change in symptoms [2 years]

    of patients who have refractory ascites after the placement of a palliative catheter in Interventional Radiology.

Secondary Outcome Measures

  1. Determine the impact ascites has on quality of life [2 years]

    via patient interviews and how this is affected by catheter placement.

  2. Monitor and describe post-catheter placement morbidity and mortality. [2 years]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients diagnosed with a stage IV malignancy or end-stage disease documented in patient's chart.

  • Patients referred to interventional radiology for treatment of refractory ascites with the placement of a permanent catheter including, but not limited to, a Tenckhoff catheter, a PleurX catheter, or a Denver Shunt.

  • Fluency in English to enable instrument and interview completion.

  • Patients must be at least 18 years of age.

  • Patients must be physically capable of completing instruments and/or interview.

  • Patients must be able to comprehend and execute informed consent.

Exclusion Criteria:
  • Unable to complete questionnaire due to a significant physical or mental deficits as assessed by the consenting professional.

  • Proxy completion is not accepted

  • Medical or psychiatric condition that, in the judgment of the investigator, prevents appropriate comprehension and execution of either the informed consent or the study instrument

Contacts and Locations

Locations

Site City State Country Postal Code
1 Memorial Sloan Kettering Cancer Center New York New York United States 10065

Sponsors and Collaborators

  • Memorial Sloan Kettering Cancer Center

Investigators

  • Principal Investigator: Piera Robson, RN, Memorial Sloan Kettering Cancer Center

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

None provided.
Responsible Party:
Memorial Sloan Kettering Cancer Center
ClinicalTrials.gov Identifier:
NCT01188746
Other Study ID Numbers:
  • 10-059
First Posted:
Aug 25, 2010
Last Update Posted:
Feb 6, 2020
Last Verified:
Feb 1, 2020
Keywords provided by Memorial Sloan Kettering Cancer Center
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 6, 2020